SkyOak Wealth’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23.7K	Hold	15,000	–	–	﹤0.01%	254
2025 Q4	$25.1K	Hold	15,000	–	–	﹤0.01%	249
2025 Q3	$25.4K	Hold	15,000	–	–	﹤0.01%	247
2025 Q2	$13.6K	Hold	15,000	–	–	﹤0.01%	243
2025 Q1	$6.77K	Hold	15,000	–	–	﹤0.01%	242
2024 Q4	$7.54K	Hold	15,000	–	–	﹤0.01%	253
2024 Q3	$13.6K	Hold	15,000	–	–	﹤0.01%	239
2024 Q2	$15K	Hold	15,000	–	–	﹤0.01%	240
2024 Q1	$22.2K	Hold	15,000	–	–	0.01%	243
2023 Q4	$16.4K	Hold	15,000	–	–	﹤0.01%	236
2023 Q3	$17.7K	Hold	15,000	–	–	0.01%	233
2023 Q2	$21.1K	Hold	15,000	–	–	0.01%	239
2023 Q1	$22.5K	Hold	15,000	–	–	0.01%	248
2022 Q4	$17.6K	Hold	15,000	–	–	0.01%	226
2022 Q3	$17K	Hold	15,000	–	–	0.01%	216
2022 Q2	$24K	Hold	15,000	–	–	0.01%	219
2022 Q1	$23K	Hold	15,000	–	–	0.01%	239
2021 Q4	$37K	Hold	15,000	–	–	0.01%	244
2021 Q3	$38K	Hold	15,000	–	–	0.01%	230
2021 Q2	$43K	Hold	15,000	–	–	0.01%	235
2021 Q1	$40K	Hold	15,000	–	–	0.01%	234
2020 Q4	$26K	Hold	15,000	–	–	0.01%	215
2020 Q3	$14K	Hold	15,000	–	–	0.01%	204
2020 Q2	$13K	Hold	15,000	–	–	﹤0.01%	237
2020 Q1	$12K	Hold	15,000	–	–	0.01%	210
2019 Q4	$13K	Buy	+15,000	New	+$12.5K	﹤0.01%	309

Other funds holding LCTX